Table 2.
Analysis method | Indicators | Unstandardized coefficients | Standardized coefficients | t | P | |
---|---|---|---|---|---|---|
B | Std. error | β | ||||
Univariate analysis | ||||||
sUA/Cr | −1.634 | 0.551 | −0.194 | −2.967 | 0.003 | |
Sex | −4.643 | 1.626 | −0.187 | −2.856 | 0.005 | |
Age | 0.085 | 0.076 | 0.074 | 1.120 | 0.264 | |
BMI | −0.985 | 0.208 | −0.300 | −4.727 | <0.001 | |
Dyslipidemia | −6.126 | 1.780 | −0.223 | −3.442 | 0.001 | |
Abnormal liver function | −7.444 | 1.383 | −0.337 | −5.383 | <0.001 | |
Abdominal obesity | −3.025 | 2.100 | −0.095 | −1.441 | 0.151 | |
Hypertension | −0.976 | 1.614 | −0.040 | −0.604 | 0.546 | |
Diabetes | −2.098 | 2.952 | −0.047 | −0.711 | 0.478 | |
Smoking history | −2.358 | 1.527 | −0.102 | −1.544 | 0.124 | |
Drinking history | −3.437 | 1.505 | −0.150 | −2.283 | 0.023 | |
| ||||||
Multivariate analysis | ||||||
sUA/Cr | −1.119 | 0.538 | −0.133 | −2.080 | 0.039 | |
Sex | −1.779 | 1.720 | −0.072 | −1.034 | 0.302 | |
BMI | −0.621 | 0.210 | −0.189 | −2.952 | 0.004 | |
Dyslipidemia | −4.320 | 1.681 | −0.157 | −2.570 | 0.011 | |
Abnormal liver function | −5.317 | 1.399 | −0.241 | −3.801 | <0.001 | |
Drinking history | −0.556 | 1.510 | −0.024 | −0.369 | 0.713 |
sUA/Cr, serum uric acid to serum creatinine ratio; BMI, body mass index.